[ Pharmaceutical Sciences Asia - ONLINE ]
E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

DOI: 10.29090/psa.2024.01.23.909Pharm Sci Asia 2024; 51(1), 19-27
 

Eugenol protects human liver HepG2 cells from H2O2-induced oxidative hepatotoxicity by maintaining ROS homeostasis, increasing IL-10 level, and upregulating CYP1B1 gene expression

Tan Suyono1*, Liena Liena1, Chrismis Novalinda Ginting1, I Nyoman Ehrich Lister1, Ermi Girsang1, Wahyu Widowati2, Fadhilah Haifa Zahiroh3, Hanna Sari Widya Kusuma3, Rizal Rizal3,4

1 Faculty of Medicine, Universitas Prima Indonesia, Jl. Sampul No. 4, Medan, North Sumatera, Indonesia
2 Faculty of Medicine, Maranatha Christian University, Jl. Prof. Drg. Surya Sumantri 65, Bandung, West Java, Indonesia
3 Aretha Medika Utama, Biomolecular and Biomedical Research Center, Jl. Babakan Jeruk II No. 9, Bandung, West Java, Indonesia
4 Biomedical Engineering Study Program, Department of Electrical Engineering, Faculty of Engineering, University of Indonesia, Depok, Indonesia


Liver injury occurs due to continuous exposure to chemical or biological hazards. Eugenol (EUG), a phenolic compound derived from red betel (Piper crocatum) leaves, has multivalent effects, primarily on antioxidant and antibacterial applications. The conducted research sought to investigate the safeguarding activities of EUG on hydrogen peroxide (H2O2)-induced toxicity of human liver HepG2 cells by examining homeostasis, interleukin 10 (IL-10), malondialdehyde (MDA) levels, reactive oxygen species (ROS) level and cytochrome P450 family 1 subfamily B member 1 (CYP1B1) gene expression. The H2O2-induced hepatotoxic cells, which served as a positive control, were treated with EUG. The measurements for IL-10 and MDA levels were made using enzyme-linked immunosorbent assay (ELISA), flow cytometry was employed for ROS level, and reverse transcription-quantitative real-time PCR (RT-qPCR) was used for CYP1B1 gene expression assay. EUG 6.25; 25 μg/mL increased IL-10 levels at 55.33 and 47.52 pg/mL compared to the positive control at 21.66 pg/mL. EUG 6.25; 25 μg/mL lowered MDA levels at 679.07 and 651.60 ng/mL compared to the positive control at 845.33 μg/mL. EUG 6.25; 25 μg/mL suppressed ROS level at 15.83 and 19.40% compared to the positive control at 24.10%. EUG 6.25; 25 μg/mL also up-regulated CYP1B1 gene expression. In conclusion, EUG exhibited excellent hepatoprotective effects in hepatotoxic cells model by maintaining ROS homeostasis, increasing IL-10, decreasing MDA levels, and upregulating CYP1B1 gene expression.


Keyword:

CYP1B1, Eugenol, Hepatotoxicity, HepG2, IL-10




Download full paper (PDF File size: 688.71 KB.)





Vol.51
No.4
October-December 2024

See other volume

 


Vol.51
No.3
July-September 2024

See other volume

 


Vol.51
No.2
April-June 2024

See other volume

 


Vol.51
No.1
January-March 2024

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University



Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0

    Copyright © 2017-2024
    Faculty of Pharmacy, Mahidol University, THAILAND
 

We use Cookies

This site uses cookies to personalise your experience and analyse site traffic. By Clicking ACCEPT or continuing to browse the site you are agreeing to our use of cookies.